News

March 11, 2018

Trial to assess dual CAR T-cell therapy for children, young adults with leukemia

A trial is underway to evaluate the use of dual chimeric antigen receptor T-cell immunotherapy for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia.
February 6, 2018

In the future, cancer treatment may be remote controlled

In the future, fighting cancer may no longer mean grueling chemotherapy, but genetically altered immune systems that can be “remote controlled.”
January 31, 2018

The future of immunotherapy treatment for pediatric cancers

Over the last several years, immunotherapy has emerged as a promising alternative to traditional forms of cancer treatment.
January 29, 2018

Seattle Children’s Hospital Launches High-Risk Leukemia Program

Seattle Children’s Hospital launched a first-of-its-kind high-risk leukemia program, with the goal of redefining care for children with leukemia who did not respond to or relapsed after treatment.